Table 3: PGG and WMG groups characterisation at time II.
|
|
PGG N = 534 |
WMG N = 169 |
p-value |
||
|
Age (years), median (IQR) |
52,82 (38,48 -6 2,19) |
60,00 (49,00 - 65,58) |
< 0.001* |
||
|
Men, n (%) |
400 |
74.91% |
121 |
74.11% |
0.420 |
|
Women, n (%) |
134 |
25.09% |
48 |
25.89% |
0.420 |
|
Vascular E., n (%) |
308 |
57.68% |
118 |
69.83% |
0.025 |
|
Traumatic E., n (%) |
195 |
36.52% |
42 |
24.85% |
0.025 |
|
Neoplastic E., n (%) |
17 |
3.18% |
2 |
1.18% |
0.546 |
|
Infectious E., n (%) |
7 |
1.31% |
1 |
0.59% |
0.688 |
|
Congenital E., n (%) |
7 |
1.31% |
6 |
3.55% |
0.199 |
PGG: Prosthetic Gait Group; WMG: Wheelchair Mobility; E: Aetiology; n: number of people; IQR: Interquartile range; p-value: Significance level according to the Fisher’s exact test; *p-value according to the Mood's test